Robert Cornell, MD
Urology · Houston, TXNPI 1457331803
Payments from drug & device makers
Across 305 payments — averaging $2277.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$618K
- Gilead$70K
- Boston Scientific$2K
- Coloplast$2K
- Astellas Pharma US Inc$942
- Axonics, Inc.$668
- plus $1K from 16 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 91 | $618,043 |
| Gilead | 11 | $69,741 |
| Boston Scientific | 66 | $2,356 |
| Coloplast | 35 | $1,965 |
| Astellas Pharma US Inc | 43 | $942 |
| Axonics, Inc. | 11 | $668 |
| Endo Pharmaceuticals Inc. | 13 | $232 |
| Medtronic(2 entities) | 3 | $168 |
| Antares Pharma, Inc. | 10 | $168 |
| Convatec Inc. | 4 | $88 |
| Ferring Pharmaceuticals Inc. | 3 | $64 |
| Olympus America Inc. | 2 | $57 |
| Acerus Pharmaceuticals Corporation | 3 | $51 |
| Halozyme Inc | 2 | $36 |
| Wound Management Technologies, Inc | 1 | $36 |
| Innovation Technologies Inc | 1 | $33 |
| Travere Therapeutics, Inc. | 1 | $20 |
| AbbVie | 1 | $20 |
| 180 Medical, Inc. | 1 | $19 |
| Reflow Medical Inc | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $16 |
| Mission Pharmacal Company | 1 | $12 |
How this compares
$694,750 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Houston
- Zvi SchiffmanHouston$17.8M
- Jose KaramHouston$5.7M
- Raj SatkunasivamHouston$2.6M
- Alan SkolnickHouston$2.4M
- Brian ChapinHouston$1.1M
- Arun RaiHouston$1M
- Ashish KamatHouston$957K
- Donald GriffithHouston$732K
- John DavisHouston$669K
- Neema NavaiHouston$607K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.